Centessa Pharmaceuticals Ltd Contracts & Agreements
44 Contracts & Agreements
- Business Finance (24 contracts)
- Business Operations (1)
- Human Resources (7)
- Intellectual Property (4)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (6)
- Amendment to Note Purchase Agreement, dated June 23, 2023, by and between the Registrant, the Purchasers party thereto and Cocoon SA LLC (Filed With SEC on August 14, 2023)
- Description of Registrants Securities (Filed With SEC on March 30, 2023)
- Amendment to Note Purchase Agreement, dated November 7, 2022, by and between the Registrant, the Purchasers party thereto and Cocoon SA LLC (Filed With SEC on March 30, 2023)
- Employment Agreement, dated as of March 30, 2022, between the registrant and David Chao (Filed With SEC on March 30, 2023)
- Sales Agreement, dated January 27, 2023, by and between the Company and SVB Securities LLC (Filed With SEC on January 27, 2023)
- Description of Registrants Securities (Filed With SEC on March 30, 2022)
- Employment Agreement, dated as of March 30, 2022, between the registrant and Saurabh Saha (Filed With SEC on March 30, 2022)
- Employment Agreement, dated as of March 30, 2022, between the registrant and Gregory M. Weinhoff, MD, MBA (Filed With SEC on March 30, 2022)
- Amendment to Note Purchase Agreement and Waiver, dated February 11, 2022 (Filed With SEC on March 30, 2022)
- One Federal Street, Boston, MA lease, dated February 7, 2022, by and between One Federal, L.P. and the Registrant (Filed With SEC on March 30, 2022)
- Form of Underwriting Agreement (Filed With SEC on May 26, 2021)
- Form of Deposit Agreement (Filed With SEC on May 24, 2021)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on May 24, 2021)
- 2021 Employee Share Purchase Plan (Filed With SEC on May 24, 2021)
- 2021 Share Option Plan and forms of award agreements thereunder (Filed With SEC on May 24, 2021)
- Form of Deed of Indemnity between the registrant and each of its directors and executive officers (Filed With SEC on May 24, 2021)
- Offer of Employment, dated December 8, 2020 as revised on December 11, 2020, by and between Marella Thorell and United Medicines Biopharma Limited (Filed With SEC on May 24, 2021)
- Registration Rights Agreement by and among the registrant and the Investors listed therein, dated January 29, 2021 (Filed With SEC on May 12, 2021)
- Employment Agreement, dated as of November 19, 2020 (as revised), between Centessa Pharmaceuticals Limited and Saurabh Saha (Filed With SEC on May 12, 2021)
- Stock Purchase Agreement, dated July 26, 2016, by and between Chiesi USA, Inc., Palladio Acquisition Sub, Inc. and Palladio Biosciences, Inc (Filed With SEC on May 12, 2021)
- Agreement and Plan of Merger, dated December 28, 2011, by and between Cornerstone Therapeutics Inc., Cohesion Merger Sub, Inc., Cardiokine, Inc., and Shareholder Representative... (Filed With SEC on May 12, 2021)
- Assignment and Bill of Sale, dated February 24, 2017, by and between Care Capital Investments II, LP, Care Capital Offshore Investments II, LP, and Palladio Biosciences, Inc (Filed With SEC on May 12, 2021)
- Assignment and Bill of Sale, dated June 2017, by and between Perseus-Soros BioPharmaceutical Fund Liquidating Trust and Palladio Biosciences, Inc (Filed With SEC on May 12, 2021)
- Assignment and Bill of Sale, dated November 7, 2017, by and between Healthcare Ventures VII, L.P., and Palladio Biosciences, Inc (Filed With SEC on May 12, 2021)
- Assignment and Bill of Sale, dated December 20, 2017, by and between Advent Private Equity Fund III A, Advent Private Equity Fund III B, Palladio Biosciences, Inc and the other... (Filed With SEC on May 12, 2021)
- License Agreement dated March 15, 2004 (as amended) between Cardiokine Biopharma LLC (a subsidiary of Palladio) and Wyeth LLC (now a subsidiary of Pfizer) (Filed With SEC on April 21, 2021)
- License Agreement dated December 7, 2016 (as amended) between ApcinteX and Cambridge Enterprise Limited (Filed With SEC on April 21, 2021)
- License Agreement dated January 2, 2020 (as amended) between Pega-One and Hoffman-la Roche (Filed With SEC on April 21, 2021)
- License Agreement dated February 4, 2015 (as amended) between Z Factor and Cambridge Enterprise Limited (Filed With SEC on April 21, 2021)
- Contingent Value Rights Agreement, dated as of January 23, 2021, by and among the Registrant, Palladio Biosciences, Inc. and the representative of the holders of contingent value... (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between ApcinteX Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between Capella Bioscience LTD, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between Inexia Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between Janpix Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between LockBody Therapeutics Ltd, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between Morphogen-IX Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between Orexia Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution agreement, dated January 23, 2021, by and between Z Factor Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution Agreement, dated January 23, 2020, by and between Pega-One, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Contribution Agreement, dated December 31, 2020 (as amended), by and between PearlRiver Bio GmbH, United Medicines Biopharma Limited, and the other parties thereto (Filed With SEC on April 21, 2021)
- Offer of Employment, dated February 27, 2021, by and between Gregory M. Weinhoff, MD, MBA and Centessa Pharmaceuticals Limited (Filed With SEC on April 21, 2021)
- Incentivization agreement, dated January 23, 2021, by and between LockBody Therapeutics Ltd, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Incentivization agreement, dated January 23, 2021, by and between Morphogen-IX Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
- Incentivization agreement, dated January 23, 2021, by and between Z Factor Limited, United Medicines Biopharma Limited and the other parties thereto (Filed With SEC on April 21, 2021)
